Biolegend, 980424, Spark Violet™ 538 anti-human HLA-DR
500microl
Catalog Number: 980424
Send an RFQ.
Category
Loading…
| Reactivity | Human |
|---|---|
| Formulation | Phosphate-buffered solution, pH 7.2, 0.09% sodium azide, 0.2% (w/v) BSA (origin USA), and a stabilizer. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Spark Violet™ 538 under optimal conditions. |
| Concentration | 200 µg/mL |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | Suggested for Flow Cytometry |
| Disclaimer | WARNINGS AND PRECAUTIONS Use appropriate personal protective equipment and safety practices per universal precautions when working with this reagent. Refer to the reagent safety data sheet. This antibody contains sodium azide. Follow federal, state and local regulations to dispose of this reagent. Sodium azide build-up in metal wastepipes may lead to explosive conditions; if disposing of reagent down wastepipes, flush with water after disposal. All specimens, samples and any material coming in contact with them should be considered potentially infectious and should be disposed of with proper precautions and in accordance with federal, state and local regulations. Do not use this reagent beyond the expiration date stated on the label. Do not use this reagent if it appears cloudy or if there is any change in the appearance of the reagent as these may be an indication of possible deterioration. Avoid prolonged exposure of the reagent or stained cells to light. Spark Violet™ 538 conjugates may interact with biomolecules present in whole blood samples from certain donors that have been exposed to Polyethylene glycol (PEG) or similar molecules. The interpretation of the staining results must be evaluated by a qualified professional using the appropriate controls. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Antigen References | Levacher M, et al. 1990. Clin Exp Immunol. 81:177-82. Terstappen L, et al. 1990. J Leukoc Biol. 48:138-48. Edwards JA, et al. 1986. J Immunol. 137:490-7. van Es A, et al. 1984. Transplantation. 37:65-9. O'Doherty U, et al. 1994. Immunology. 82:487-93. Thomas R, et al. 1994. J Immunol. 153:4016-28. Grouard G, et al. 1996. Nature. 384:364-7. |
|---|
| Clone | L243 |
|---|
| Other Names | Major Histocompatibility Class II, MHC class II |
|---|
| Isotype | Mouse IgG2a, κ |
|---|
